CHAPTER 1. Industry Overview of Parenteral Nutrition Market
1.1. Definition and Scope
1.1.1. Definition of Parenteral Nutrition
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Parenteral Nutrition Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Parenteral Nutrition Market By Nutrient Type
1.2.3. Parenteral Nutrition Market By Consumer
1.2.4. Parenteral Nutrition Market By End-use
1.2.5. Parenteral Nutrition Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data End-use
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Parenteral Nutrition Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Parenteral Nutrition Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Parenteral Nutrition Market By Nutrient Type
4.1. Introduction
4.2. Parenteral Nutrition Revenue By Nutrient Type
4.2.1. Parenteral Nutrition Revenue (USD Million) and Forecast, By Nutrient Type, 2018-2030
4.2.2. Carbohydrates
4.2.2.1. Carbohydrates Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. Trace Elements
4.2.3.1. Trace Elements Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.4. Single Dose Amino Acid Solution
4.2.4.1. Single Dose Amino Acid Solution Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.5. Parenteral Lipid Emulsion
4.2.5.1. Parenteral Lipid Emulsion Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.6. Vitamins & Minerals
4.2.6.1. Vitamins & Minerals Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Parenteral Nutrition Market By Consumer
5.1. Introduction
5.2. Parenteral Nutrition Revenue By Consumer
5.2.1. Parenteral Nutrition Revenue (USD Million) and Forecast, By Consumer, 2018-2030
5.2.2. Children and Newborns
5.2.2.1. Children and Newborns Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Adult
5.2.3.1. Adult Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. Parenteral Nutrition Market By End-use
6.1. Introduction
6.2. Parenteral Nutrition Revenue By End-use
6.2.1. Parenteral Nutrition Revenue (USD Million) and Forecast, By End-use, 2018-2030
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.3. Homecare
6.2.3.1. Homecare Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.4. Clinics
6.2.4.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.5. Others
6.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Parenteral Nutrition Market By Country
7.1. North America Parenteral Nutrition Market Overview
7.2. U.S.
7.2.1. U.S. Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
7.2.2. U.S. Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
7.2.3. U.S. Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
7.3. Canada
7.3.1. Canada Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
7.3.2. Canada Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
7.3.3. Canada Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Parenteral Nutrition Market By Country
8.1. Europe Parenteral Nutrition Market Overview
8.2. U.K.
8.2.1. U.K. Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
8.2.2. U.K. Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
8.2.3. U.K. Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
8.3. Germany
8.3.1. Germany Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
8.3.2. Germany Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
8.3.3. Germany Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
8.4. France
8.4.1. France Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
8.4.2. France Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
8.4.3. France Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
8.5. Spain
8.5.1. Spain Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
8.5.2. Spain Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
8.5.3. Spain Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
8.6.2. Rest of Europe Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
8.6.3. Rest of Europe Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Parenteral Nutrition Market By Country
9.1. Asia Pacific Parenteral Nutrition Market Overview
9.2. China
9.2.1. China Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
9.2.2. China Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
9.2.3. China Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
9.3. Japan
9.3.1. Japan Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
9.3.2. Japan Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
9.3.3. Japan Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
9.4. India
9.4.1. India Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
9.4.2. India Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
9.4.3. India Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
9.5. Australia
9.5.1. Australia Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
9.5.2. Australia Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
9.5.3. Australia Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
9.6. South Korea
9.6.1. South Korea Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
9.6.2. South Korea Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
9.6.3. South Korea Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
9.7.2. Rest of Asia-Pacific Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
9.7.3. Rest of Asia-Pacific Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Parenteral Nutrition Market By Country
10.1. Latin America Parenteral Nutrition Market Overview
10.2. Brazil
10.2.1. Brazil Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
10.2.2. Brazil Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
10.2.3. Brazil Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
10.3. Mexico
10.3.1. Mexico Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
10.3.2. Mexico Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
10.3.3. Mexico Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
10.4.2. Rest of Latin America Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
10.4.3. Rest of Latin America Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Parenteral Nutrition Market By Country
11.1. Middle East & Africa Parenteral Nutrition Market Overview
11.2. GCC
11.2.1. GCC Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
11.2.2. GCC Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
11.2.3. GCC Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
11.3. South Africa
11.3.1. South Africa Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
11.3.2. South Africa Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
11.3.3. South Africa Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030
11.4.2. Rest of Middle East & Africa Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030
11.4.3. Rest of Middle East & Africa Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Parenteral Nutrition Market
12.1. Parenteral Nutrition Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Parenteral Nutrition Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Actavis, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2021
13.1.3.2. Actavis, Inc. 2021 Parenteral Nutrition Business Regional Distribution
13.1.4. Product/Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. B. Braun Melsungen AG
13.3. Aculife (Nirlife)
13.4. Sichuan Kelun Pharmaceutical Co. Ltd.
13.5. Baxter International, Inc.
13.6. Hospira, Inc.
13.7. Grifols International S.A.
13.8. Otsuka Pharmaceutical Factory, Inc.
13.9. Fresenius Kabi AG
13.10. Vifor Pharma.
The estimated value of global parenteral nutrition market in 2021 was accounted to be USD 6,231 Million.
The projected CAGR parenteral nutrition market during the analysis period of 2022 to 2030 is 5.9%.
The prominent players of the global parenteral nutrition market are Actavis, Inc., B. Braun Melsungen AG, Aculife (Nirlife), Sichuan Kelun Pharmaceutical Co. Ltd., Baxter International, Inc., Hospira, Inc., Grifols International S.A., Otsuka Pharmaceutical Factory, Inc., Fresenius Kabi AG, and Vifor Pharma.
North America held the dominating parenteral nutrition market during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for parenteral nutrition market during the analysis period of 2022 to 2030.
Increasing prevalence of metabolic illnesses and rapidly expanding malnutrition across the globe drives the growth of global parenteral nutrition market.
Based on end-use, hospitals segment is expected to hold the maximum share of the parenteral nutrition market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date